Deferiprone to Delay Dementia (The 3D study) [ 2017 - 2021 ]

Research Grant

Researchers: A/Pr Michael Woodward (Principal investigator) ,  Prof Ashley Bush (Principal investigator) ,  A/Pr Olivier Salvado ,  A/Pr Stephen Macfarlane ,  Dr Kathryn Ellis
View all 6 related researchers

Brief description There are currently no drugs available to prevent or slow deterioration in Alzheimer’s disease – which is a major incurable dementia. Our recent findings demonstrate that high brain iron levels worsen brain performance and cause people to develop Alzheimer’s disease at an earlier point in time. We propose a clinical trial of deferiprone, a drug that lowers brain iron levels, to determine if this would slow deterioration in Alzheimer’s disease once it is first detected.

Funding Amount $AUD 1,901,270.28

Funding Scheme Project Grants

Notes Standard Project Grant